The Supraventricular Tachycardia market benefits from aging populations, technological advances like catheter ablation, rising cardiovascular awareness, and wearable diagnostics. Growth is supported ...
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results